Hattori, Itaro <br/><br/>
Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice.  [electronic resource] 

 -  Antioxidants & redox signaling  Feb 2004 
 - 81-7 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-0864 
<br/><br/><label>Standard No.: </label>10.1089/152308604771978372  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain--drug effects<br/>Brain Infarction--pathology<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Injections, Intravenous<br/>Ischemic Attack, Transient--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mitogen-Activated Protein Kinases--drug effects<br/>Oxidation-Reduction--drug effects<br/>Proteins--metabolism<br/>Recombinant Proteins--therapeutic use<br/>Thioredoxins--therapeutic use<br/>p38 Mitogen-Activated Protein Kinases